Dr. Yuichiro Hiura and colleagues at Osaka University reported, nausea and loss of appetite is a challenge for chemotherapy patients and the findings of Ghrelin infusion offers an alternative to help advanced cancer patients to more easily get your appetite so it will run its full potential treatment.
A study found that Ghrelin may help prevent loss of appetite and nausea caused by cancer drugs in the period during chemotherapy.
Studies conducted in Japan are saying that Ghrelin is a hormone secreted by the intestine to increase appetite.
In the study, Japanese researchers tested the effects of Ghrelin infusion in 41 patients who underwent the treatment of advanced cancer using the drug cisplatin.
Half of the patients were randomly assigned to use Ghrelin infusion twice a day before eating more than one week after chemotherapy. While the rest were given intravenous saline (saline infusion).
Overall, more than half of the saline group expressed no symptoms of nausea, compared to patients taking Ghrelin. While half of the saline group complained of anorexia or loss of appetite during chemotherapy.
